SINGAPORE (Aug 26): UOB Kay Hian is looking after its “hold” call proposal on IHH Healthcare, bringing down its objective cost from $2.31 beforehand to $2.14 as 2Q income were dragged around startup expenses of new doctor’s facilities and additionally higher staff costs.
In a Friday report, examiners Thai Wei Ying and Andrew Chow say they have brought down their net benefit figures for IHH by 6%-12% for 2016-17 individually subsequent to calculating in higher compensation expenses to meet higher staffing necessity, higher pre-working costs for Gleneagles Hong Kong, and higher start-up expenses from new doctor’s facilities.
Hot Stocks for Intra & Contra Day Trader in SGX Market :
- Mary Chia
So Earn more trade on These Stocks . . . . . .